VeriMomБезопасен ли potassium phenylbenzimidazole sulfonate при беременности?
Potassium phenylbenzimidazole sulfonate (the water‑soluble salt of phenylbenzimidazole sulfonic acid, INCI often reported as Phenylbenzimidazole Sulfonic Acid/its salts) is a UVB filter with no harmonised reproductive classification and no convincing animal or human reproductive/toxic endocrine data in regulatory reviews; CIR/SCCS assessments do not identify reproductive hazard. Dermal absorption is low but measurable for this class of water‑soluble UV filters, so exposure in pregnancy is low but not zero (SCCS/CosIng/PubChem summaries).
Related ingredients
Frequently asked questions
- Безопасен ли potassium phenylbenzimidazole sulfonate при беременности?
- Potassium phenylbenzimidazole sulfonate (the water‑soluble salt of phenylbenzimidazole sulfonic acid, INCI often reported as Phenylbenzimidazole Sulfonic Acid/its salts) is a UVB filter with no harmonised reproductive classification and no convincing animal or human reproductive/toxic endocrine data in regulatory reviews; CIR/SCCS assessments do not identify reproductive hazard. Dermal absorption is low but measurable for this class of water‑soluble UV filters, so exposure in pregnancy is low but not zero (SCCS/CosIng/PubChem summaries).
- Безопасен ли potassium phenylbenzimidazole sulfonate при грудном вскармливании?
- Same rationale as for pregnancy: no regulatory harmonised reproductive or lactation hazard identified and no mechanistic evidence for transfer into milk in available safety assessments; dermal exposure is low but measurable, so postpartum topical use implies low maternal systemic exposure and therefore low likelihood of meaningful transfer into breast milk (SCCS/CosIng/PubChem).
- Безопасен ли potassium phenylbenzimidazole sulfonate для кожи малыша?
- No infant‑specific reproductive or developmental hazards reported; however, due to immature infant barrier and higher surface‑area‑to‑body‑weight, measurable dermal absorption of this water‑soluble UV filter warrants increasing exposure score for 0–3 year skin to moderate. Regulatory safety reviews (SCCS/CosIng) do not flag developmental or endocrine concerns but note exposure considerations for application to young children.
- Как VeriMom оценивает potassium phenylbenzimidazole sulfonate?
- VeriMom оценивает potassium phenylbenzimidazole sulfonate в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы potassium phenylbenzimidazole sulfonate при беременности?
- См. наш список безопасных альтернатив potassium phenylbenzimidazole sulfonate с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.